Li Min is a passionate and seasoned commercial executive with over 20 years of Asia-focused leadership experience driving transformative growth across pharmaceuticals, consumer healthcare, and consultancy sectors (MSD, Pfizer, Axios, Zuellig, Ipsen). Recognized for doubling revenues and accelerating market share gains, he combines strategic vision with operational excellence to redesign business models, optimize portfolios, and negotiate high-value, multi-country alliances.
Adept at managing P&Ls, Li Min has launched various pharmaceutical and CHC products, spearheaded patient-centric market access programs, and led cross-functional teams to deliver measurable profitability improvements. His expertise spans business development, strategic negotiation, and partnership management, with a track record of closing multi-million dollar and multi-country deals that balance commercial success with healthcare accessibility.
As a collaborative leader, he champions single accountability and Kaizen-driven efficiency, building high-performing regional teams that thrive on innovation and adaptability. Currently a Fractional Leader, Li Min advises multinationals on unlocking Asia’s healthcare potential through scalable strategies and agile execution.
Veritux independent consultants are available where you need them – in all major markets and every global region.
